Keyphrases
Outpatient Clinic
100%
Diabetes
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Low-grade Inflammation
100%
Vascular Complications
66%
Macrophage-derived Chemokine
50%
Tumor Necrosis Factor-α
33%
Hemoglobin A1c (HbA1c)
33%
Glycemic Control
33%
Serum Levels
33%
Interleukin-12 (IL-12)
33%
Interleukin-15 (IL-15)
33%
Eotaxin
33%
Interleukin
33%
Denmark
16%
C-reactive Protein Level
16%
C-reactive Protein
16%
Interleukin-6
16%
Healthy Controls
16%
University Hospital
16%
Interleukin-10
16%
Comorbidity
16%
Obesity
16%
Diabetes Clinic
16%
Diabetes Complications
16%
Immunoassay
16%
Inhibitor Therapy
16%
A1c Levels
16%
Sectional Analysis
16%
Inflammatory Biomarkers
16%
Clinical Aspects
16%
Thymus
16%
Interleukin-7 (IL-7)
16%
Dipeptidyl peptidase-4 (DPP-4)
16%
Aalborg
16%
Endocrinology
16%
Activation-regulated Chemokine
16%
Medicine and Dentistry
Outpatient
100%
Diabetes
100%
Maturity Onset Diabetes of the Young
100%
Cross Sectional Study
100%
Macrophage Derived Chemokine
50%
Cytokine
33%
C Reactive Protein
33%
Hemoglobin A1c
33%
Body Weight
33%
Tumor Necrosis
33%
Interleukin 15
33%
Interleukin 12
33%
Eotaxin
33%
Drug Therapy
16%
Interleukin 10
16%
Interleukin 6
16%
Biological Marker
16%
Glycemic
16%
Glycemic Control
16%
Clinical Feature
16%
Immunoassay
16%
Complications of Diabetes Mellitus
16%
Dipeptidyl Peptidase-4 Inhibitor
16%
Endocrinology
16%
Interleukin 7
16%
Thymus and Activation Regulated Chemokine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cross-Sectional Study
100%
Inflammation
100%
Non Insulin Dependent Diabetes Mellitus
100%
Macrophage Derived Chemokine
50%
C Reactive Protein
33%
Cytokine
33%
Hemoglobin A1c
33%
Tumor Necrosis
33%
Interleukin 12
33%
Interleukin 15
33%
Eotaxin
33%
Comorbidity
16%
Interleukin 10
16%
Interleukin 6
16%
Biological Marker
16%
Cross Sectional Study
16%
Diabetic Complication
16%
Immunoassay
16%
Clinical Feature
16%
Dipeptidyl Peptidase IV Inhibitor
16%
Interleukin 7
16%
Thymus and Activation Regulated Chemokine
16%